Peel Hunt reissued their add rating on shares of Abcam (LON:ABC) in a research note issued to investors on Thursday, ThisIsMoney.Co.Uk reports.

ABC has been the topic of a number of other research reports. Liberum Capital reissued a hold rating and issued a GBX 1,370 ($18.02) target price (up previously from GBX 1,230 ($16.18)) on shares of Abcam in a report on Friday, January 10th. Royal Bank of Canada lowered their target price on Abcam from GBX 1,300 ($17.10) to GBX 1,250 ($16.44) and set a sector performer rating on the stock in a report on Wednesday, December 18th. Finally, Panmure Gordon downgraded Abcam to a sell rating in a report on Wednesday, December 18th. One analyst has rated the stock with a sell rating, four have given a hold rating and one has assigned a buy rating to the stock. The stock has an average rating of Hold and an average target price of GBX 1,310.80 ($17.24).

ABC stock traded down GBX 5 ($0.07) during trading on Thursday, reaching GBX 1,300 ($17.10). The stock had a trading volume of 415,210 shares, compared to its average volume of 497,233. Abcam has a 52 week low of GBX 1,058 ($13.92) and a 52 week high of GBX 1,523 ($20.03). The stock’s 50 day moving average is GBX 1,369.04 and its two-hundred day moving average is GBX 1,265.58. The firm has a market cap of $2.68 billion and a PE ratio of 59.63.

In other Abcam news, insider Jonathan Simon Milner sold 1,100,000 shares of the stock in a transaction dated Friday, January 24th. The stock was sold at an average price of GBX 1,412 ($18.57), for a total value of £15,532,000 ($20,431,465.40).

About Abcam

Abcam plc, together with its subsidiaries, produces and distributes research-grade antibodies and associated protein research tools worldwide. The company primarily offers primary and secondary antibodies; ELISA, matched antibody pairs and multiplex immunoassays; cell and tissue imaging tools; cellular and biochemical assays; proteins and peptides; proteomics tools; agonists, antagonists, activators, and inhibitors; lysates; and multiplex miRNA assays.

See Also: Support Level

Analyst Recommendations for Abcam (LON:ABC)

Receive News & Ratings for Abcam Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abcam and related companies with MarketBeat.com's FREE daily email newsletter.